Case report: Fatal hemoptysis after effective treatment with tislelizumab and anlotinib in pulmonary sarcomatoid carcinoma

Pulmonary sarcomatoid carcinoma (PSC), a rare non-small cell lung cancer (NSCLC) subtype, poses diagnostic and treatment difficulties. Current research explores targeted therapies and immunotherapy to improve patient outcomes. This case report details a male patient diagnosed with PSC via pathology....

ver descrição completa

Detalhes bibliográficos

Principais autores:	Chen-Wei Pu, Yong-Fen Ma, Jing-Jing Peng, Zhen-Zhen Wang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2024-09-01
coleção:	Frontiers in Oncology
Assuntos:	tislelizumab anlotinib pulmonary sarcomatoid carcinoma hemoptysis adverse effects
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1445358/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!